Protamine
FDA Approves Dotarem, a New MRI Agent »
"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.
Dotarem is a gadolinium-based"...
Protamine
CLINICAL PHARMACOLOGY
When administered alone, protamine (protamines) has an anticoagulant effect. However, when it is given in the presence of heparin (which is strongly acidic), a stable salt is formed which results in the loss of anticoagulant activity of both drugs.
Protamine sulfate (protamine (protamines) s) has a rapid onset of action.
Neutralization of heparin occurs within five minutes after intravenous administration. Although the metabolic fate of the heparin-protamine (protamines) complex has not been elucidated, it has been postulated that protamine sulfate (protamine (protamines) s) in the heparin-protamine (protamines) complex may be partially metabolized or may be attacked by fibrinolysin, thus freeing heparin.
Last reviewed on RxList: 11/21/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Protamine Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
